Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sa...

FDA Recall #D-1065-2014 — Class III — November 13, 2013

Recall #D-1065-2014 Date: November 13, 2013 Classification: Class III Status: Terminated

Product Description

Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05.

Reason for Recall

Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

Recalling Firm

Forest Pharmaceuticals Inc — Earth City, MO

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

111,384 sample packs

Distribution

Nationwide and Puerto Rico.

Code Information

Lot 1112467 Exp. 02/15

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated